We observed the attenuation of the severity of colitis in mice treated with MC-170073, as indicated by the downregulation of macroscopic and histological scores along with lower levels of MPO and the proinflammatory cytokine IL-1β (Fig. 3, A–F). This evidence concerns the gene IL1B and colitis.